Literature DB >> 21684409

Physician-initiated rapid HIV testing in an urban emergency department: comparison of testing using a point-of-care versus a laboratory model.

Douglas A E White1, Tony Tran, Patrick J Dideum, Farnaz Vahidnia, Danielle M Gordon, Valerie Ng, Bradley W Frazee.   

Abstract

STUDY
OBJECTIVE: We compare the outcomes of 2 models of physician-initiated rapid HIV testing in an emergency department (ED).
METHODS: One-year retrospective cohort comparing 2 6-month models of physician-initiated rapid HIV testing, point-of-care versus laboratory. Patients aged 12 years or older and able to give verbal consent were eligible for physician-initiated rapid HIV testing if their treating physician believed testing was clinically indicated. During the point-of-care phase, nursing staff performed oral fluid testing. During the laboratory phase, the laboratory performed whole-blood testing. The proportion of potentially eligible patients who had physician-initiated rapid HIV testing ordered (order rate), proportion of ordered tests completed (test completion rate), and proportion of potentially eligible patients who completed testing (overall testing rate) during each phase were assessed. ED length of stay and testing times were also compared.
RESULTS: For the point-of-care versus laboratory phase, respectively, there were 24,345 potentially eligible patients versus 26,363; order rate was 3.3% versus 2.4% (P<.001); test completion rate was 75.3% versus 86.8% (P<.001); overall testing rate was 2.5% versus 2.1% (P=.009). Eighteen (3.0%) of the point-of-care-tested patients and 15 (2.7%) of the laboratory-tested patients had reactive tests (P=0.02). The total testing time was greater in the laboratory phase (88 versus 66 minutes; P<.001); however, there was no significant difference in the length of stay between phases (6.2 versus 6.9 hours; P=.15).
CONCLUSION: Relatively few ED patients undergo physician-initiated rapid HIV testing regardless of whether a point-of-care or laboratory approach is used. Differences exist in most outcome measures when point-of-care and laboratory models are compared, which should be considered when testing is implemented.
Copyright © 2011. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21684409     DOI: 10.1016/j.annemergmed.2011.03.025

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

1.  Lessons Learned From the Development and Parameterization of a Computer Simulation Model to Evaluate Task Modification for Health Care Providers.

Authors:  Parastu Kasaie; W David Kelton; Rachel M Ancona; Michael J Ward; Craig M Froehle; Michael S Lyons
Journal:  Acad Emerg Med       Date:  2017-11-11       Impact factor: 3.451

2.  Providers' perceptions of the factors influencing the implementation of the New York State mandatory HIV testing law in two Urban academic emergency departments.

Authors:  Rebecca Schnall; Sunday Clark; Susan Olender; Jeremy D Sperling
Journal:  Acad Emerg Med       Date:  2013-03       Impact factor: 3.451

3.  HIV testing practices by clinical service before and after revised testing guidelines in a Swiss University Hospital.

Authors:  Katharine E A Darling; Olivier Hugli; Rachel Mamin; Cristina Cellerai; Sebastien Martenet; Alexandre Berney; Solange Peters; Renaud A Du Pasquier; Patrick Bodenmann; Matthias Cavassini
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

Review 4.  Effect of rapid HIV testing on HIV incidence and services in populations at high risk for HIV exposure: an equity-focused systematic review.

Authors:  Kevin Pottie; Olanrewaju Medu; Vivian Welch; Govinda P Dahal; Mark Tyndall; Tamara Rader; George Wells
Journal:  BMJ Open       Date:  2014-12-15       Impact factor: 2.692

5.  Comparison of HIV Screening Strategies in the Emergency Department: A Randomized Clinical Trial.

Authors:  Jason S Haukoos; Michael S Lyons; Richard E Rothman; Douglas A E White; Emily Hopkins; Meggan Bucossi; Andrew H Ruffner; Rachel M Ancona; Yu-Hsiang Hsieh; Stephen C Peterson; Danielle Signer; Matthew F Toerper; Mustapha Saheed; Sarah K Pfeil; Tamara Todorovic; Alia A Al-Tayyib; Lucy Bradley-Springer; Jonathan D Campbell; Edward M Gardner; Sarah E Rowan; Allison L Sabel; Mark W Thrun
Journal:  JAMA Netw Open       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.